We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Innovaderma Plc | LSE:IDP | London | Ordinary Share | GB00BT9PTW34 | ORD EUR0.10 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 29.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMIDP
RNS Number : 3599Z
InnovaDerma PLC
18 September 2020
LEI: 213800WRAP6W8VDL6B38
InnovaDerma PLC
("InnovaDerma" or the "Company")
Notice of Results
InnovaDerma (LSE: IDP), a UK developer of beauty, personal care and life sciences products, will announce its full year results for the year ended 30 June 2020 on Wednesday, 30 September 2020.
The management of InnovaDerma will deliver an online results presentation open to all existing and potential investors via the Investor Meet Company platform on Wednesday, 30 September 2020 at 9am UK time.
Investors can sign up for free via: https://www.investormeetcompany.com/innovaderma-plc/register-investor
Investors who have already registered and added to meet the Company will be automatically invited.
The presentation is in line with InnovaDerma's commitment to ensuring appropriate communication structures are in place for all sections of its shareholder base so that its strategy, business model and performance are clearly understood.
Questions can be submitted pre-event through the platform or at any time during the live presentation. Management may not be in a position to answer every question it receives but will address those it can while remaining within the confines of information already disclosed to the market. Responses to the Q&A from the live presentation will be published at the earliest opportunity on the Investor Meet Company platform.
Investor feedback can also be submitted directly to management post-event to ensure the Company can understand the views of all elements of its shareholder base.
Further enquiries
InnovaDerma Joe Bayer +61 (0)3 9863 8030 www.innovaderma.com +44 (0)20 7930 0777 finnCap Ltd Geoff Nash/ Kate Bannatyne +44 (0)207 220 0500 Alice Lane/Manasa Patil - Corporate www.finncap.com Broking --------------------------- TB Cardew Shan Shan Willenbrock/Tom Allison + 44 (0)20 7930 0777 Olivia Rosser innovaDerma@tbcardew.com ---------------------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
NOREAKNXFSNEEFA
(END) Dow Jones Newswires
September 18, 2020 02:00 ET (06:00 GMT)
1 Year Innovaderma Chart |
1 Month Innovaderma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions